308 related articles for article (PubMed ID: 17084618)
1. Cellular principles underlying normal and pathological activity in the subthalamic nucleus.
Bevan MD; Atherton JF; Baufreton J
Curr Opin Neurobiol; 2006 Dec; 16(6):621-8. PubMed ID: 17084618
[TBL] [Abstract][Full Text] [Related]
2. Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered.
Braak H; Del Tredici K
Exp Neurol; 2008 Jul; 212(1):226-9. PubMed ID: 18501351
[TBL] [Abstract][Full Text] [Related]
3. Effects of subthalamic nucleus lesions and stimulation upon glutamate levels in the dopamine-depleted rat striatum.
Walker RH; Koch RJ; Sweeney JE; Moore C; Meshul CK
Neuroreport; 2009 May; 20(8):770-5. PubMed ID: 19373115
[TBL] [Abstract][Full Text] [Related]
4. Dopamine-dependent high-frequency oscillatory activity in thalamus and subthalamic nucleus of patients with Parkinson's disease.
Kane A; Hutchison WD; Hodaie M; Lozano AM; Dostrovsky JO
Neuroreport; 2009 Nov; 20(17):1549-53. PubMed ID: 19829159
[TBL] [Abstract][Full Text] [Related]
5. Frequency-selectivity of a thalamocortical relay neuron during Parkinson's disease and deep brain stimulation: a computational study.
Cagnan H; Meijer HG; van Gils SA; Krupa M; Heida T; Rudolph M; Wadman WJ; Martens HC
Eur J Neurosci; 2009 Oct; 30(7):1306-17. PubMed ID: 19788577
[TBL] [Abstract][Full Text] [Related]
6. GABAergic control of the subthalamic nucleus.
Bevan MD; Hallworth NE; Baufreton J
Prog Brain Res; 2007; 160():173-88. PubMed ID: 17499114
[TBL] [Abstract][Full Text] [Related]
7. Zolpidem modulates GABA(A) receptor function in subthalamic nucleus.
Chen L; Xie JX; Fung KS; Yung WH
Neurosci Res; 2007 May; 58(1):77-85. PubMed ID: 17337310
[TBL] [Abstract][Full Text] [Related]
8. Striatal dysfunction increases basal ganglia output during motor cortex activation in parkinsonian rats.
Belluscio MA; Riquelme LA; Murer MG
Eur J Neurosci; 2007 May; 25(9):2791-804. PubMed ID: 17561844
[TBL] [Abstract][Full Text] [Related]
9. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
[TBL] [Abstract][Full Text] [Related]
10. Induction of immediate early gene expression by high-frequency stimulation of the subthalamic nucleus in rats.
Schulte T; Brecht S; Herdegen T; Illert M; Mehdorn HM; Hamel W
Neuroscience; 2006; 138(4):1377-85. PubMed ID: 16460881
[TBL] [Abstract][Full Text] [Related]
11. [Possible mechanisms of involvement of the subthalamic nucleus and structures interconnected with this nucleus in movement disorders evoked by dopamine depletion].
Sil'kis IG
Usp Fiziol Nauk; 2005; 36(2):66-83. PubMed ID: 15909665
[TBL] [Abstract][Full Text] [Related]
12. Gender-related differences in the human subthalamic area: a local field potential study.
Marceglia S; Mrakic-Sposta S; Foffani G; Cogiamanian F; Caputo E; Egidi M; Barbieri S; Priori A
Eur J Neurosci; 2006 Dec; 24(11):3213-22. PubMed ID: 17156382
[TBL] [Abstract][Full Text] [Related]
13. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
[TBL] [Abstract][Full Text] [Related]
14. Divergent regulatory mechanisms governing BDNF mRNA expression in cerebral cortex and substantia nigra in response to striatal target ablation.
Rite I; Machado A; Cano J; Venero JL
Exp Neurol; 2005 Mar; 192(1):142-55. PubMed ID: 15698628
[TBL] [Abstract][Full Text] [Related]
15. Motor cortical control of internal pallidal activity through glutamatergic and GABAergic inputs in awake monkeys.
Tachibana Y; Kita H; Chiken S; Takada M; Nambu A
Eur J Neurosci; 2008 Jan; 27(1):238-53. PubMed ID: 18093168
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease is a neuropsychiatric disorder.
Agid Y; Arnulf I; Bejjani P; Bloch F; Bonnet AM; Damier P; Dubois B; François C; Houeto JL; Iacono D; Karachi C; Mesnage V; Messouak O; Vidailhet M; Welter ML; Yelnik J
Adv Neurol; 2003; 91():365-70. PubMed ID: 12442695
[No Abstract] [Full Text] [Related]
17. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
[TBL] [Abstract][Full Text] [Related]
18. Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction.
Costa RM; Lin SC; Sotnikova TD; Cyr M; Gainetdinov RR; Caron MG; Nicolelis MA
Neuron; 2006 Oct; 52(2):359-69. PubMed ID: 17046697
[TBL] [Abstract][Full Text] [Related]
19. GABAergic interneurons in human subthalamic nucleus.
Lévesque JC; Parent A
Mov Disord; 2005 May; 20(5):574-84. PubMed ID: 15645534
[TBL] [Abstract][Full Text] [Related]
20. Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network.
Magill PJ; Bolam JP; Bevan MD
Neuroscience; 2001; 106(2):313-30. PubMed ID: 11566503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
